Natalizumab Biosimilar - Research Grade
Bulk Natalizumab Biosimilar - Research Grade
Product Benefits:ichorbio's Natalizumab Biosimilar - Research Grade is manufactured in a cGMP compliant facility.
Size:ichorbio's research grade natalizumab biosimilar is available in the following sizes: 5mg, 10mg, 20mg, 50mg, 100mg ichorbio regularly manufactures bulk multi-gram amounts of our natalizumab biosimilar - research grade. Please contact us for pricing.
Target:α4β1 integrin
Clone:n/a
Isotype:Human IgG4
Other Names:alpha-4 integrin
Host:CHO Cells
Species Reactivity:Human
Specificity:Detects human α4β1 integrin.
Purification Method:This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.
Background:Natalizumab biosimilar - research grade is a humanized monoclonal antibody that blocks α4β1 integrin. It is an IgG1 kappa immunoglobulin with an approximate molecular weight of 149 kDa.
Concentration:1.0 - 5.0 mg/ml
Formulation:Sterile, preservative-free, buffer includes sodium chloride; sodium phosphate, monobasic, monohydrate; sodium phosphate, dibasic, heptahydrate; polysorbate 80, pH 6.1. BSA and Azide free.
Purity:>98% by SDS-PAGE and HPLC
Endotoxin:≤ 1.0 EU/mg as determined by the LAL method
Storage:Natalizumab is stable for at least four (4) weeks when stored sterile at 2-8°C. For long term storage aseptically aliquot in working volumes without diluting and store at –80°C. Avoid Repeated Freeze Thaw Cycles.
Applications:Functional Assays
Application Notes:Each investigator should determine their own optimal working dilution for specific applications.
Isotype Control: Use: ichorbio's natalizumab biosimilar is for research use only (RUO).Concentration | 9.73mg/ml |
---|---|
isotype | Human IgG4 |
Host | CHO Cells |